Category Health Tech

Galderma’s Nemluvio® (Nemolizumab) Approved for Atopic Dermatitis and Prurigo Nodularis in the UK and Switzerland

Galderma’s Nemluvio® (Nemolizumab) Approved for Atopic Dermatitis and Prurigo Nodularis in the UK and Switzerland Galderma has announced that the United Kingdom’s Medicines and Healthcare Products Regulatory Agency (MHRA) and…

Read MoreGalderma’s Nemluvio® (Nemolizumab) Approved for Atopic Dermatitis and Prurigo Nodularis in the UK and Switzerland

Pfizer’s TALZENNA® and XTANDI® Combo Enhances Survival in Metastatic Castration-Resistant Prostate Cancer

Pfizer’s TALZENNA® and XTANDI® Combo Enhances Survival in Metastatic Castration-Resistant Prostate Cancer Pfizer Inc. (NYSE: PFE) has announced promising results from the Phase 3 TALAPRO-2 study, which tested TALZENNA® (talazoparib),…

Read MorePfizer’s TALZENNA® and XTANDI® Combo Enhances Survival in Metastatic Castration-Resistant Prostate Cancer